June 15, 2011
Maynard Firm Names New CEO
PHOTO/COURTESY
Michael Webb has been named the new president and CEO of Allegro Diagnostics in Maynard.
By Brandon Butler
Maynard biotech firm Allegro Diagnostics has named Michael Webb as its new president and CEO.
Webb comes to the company after founding and serving as president and CEO of Anchor Therapeutics in Cambridge. He's the former chairman of the Massachusetts Biotechnology Council and also served as president and CEO of Lexington-based Epix Pharmaceuticals, a company that folded in 2009.
Allegro is a molecular diagnostics company that provides genome testing for the diagnosis of lung cancer and other lung diseases.
WBJ Web Partners
Most Recent
Most Recent
0 Comments